AC Immune SA
Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates
Last updated:
Abstract:
The present invention relates to novel compounds that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
Status:
Application
Type:
Utility
Filling date:
29 Jan 2020
Issue date:
28 Apr 2022